Inhibition of aromatase activity by flavonoids


In searching for potent cancer chemopreventive agents from synthetic or natural products, 28 randomly selected flavonoids were screened for inhibitory effects against partially purified aromatase prepared from human placenta. Over 50% of the flavonoids significantly inhibited aromatase activity, with greatest activity being demonstrated with apigenin (IC50: 0.9 μg/mL), chrysin (IC50: 1.1 μg/mL), and hesperetin (IC50: 1.0 μg/mL).

This is a preview of subscription content, access via your institution.

References Cited

  1. Brodie, A. M. H. and Njar, V. C. O.: Aromatase inhibitors and breast cancer.Semin. Oncol., 23, 10–20 (1996).

    PubMed  CAS  Google Scholar 

  2. Conn, P. M. and Crowley, W. F., Gonadotrophin-releasing hormone and its analogues.N. Engl. J. Med., 324, 93–103 (1991).

    PubMed  CAS  Google Scholar 

  3. Harvey, H. A.: Aromatase inhibitors in clinical practice: Current status and a look to the future.Semin. Oncol., 23, Suppl., 9, 33–38 (1996).

    PubMed  CAS  Google Scholar 

  4. Hoffman, P. G., Jones, L. A., Kuhn, R. W. and Sitteri, P. K.: Progesterone receptors: saturation analysis by a solid phase hydroxyapatite adsorption technique.Cancer, 46, 2801–2804 (1980).

    PubMed  Article  CAS  Google Scholar 

  5. Kellis, J. T. Jr. and Vickery, L. E.: Purification and characterization of human placental aromatase cytochrome P-450,J. Biol. Chem., 262, 4413–4420 (1987).

    PubMed  CAS  Google Scholar 

  6. Rabe, T., Rabe, D. and Punnebaum, B.: New aromatase assay and its application for inhibitory studies of aminogluthetimide on microsomes of human term placenta.J. Steroid Biochem., 7, 305–309 (1982).

    Google Scholar 

  7. Santen, R. J., Manni, A. and Harvey, H. A.: Endocrine treatment of breast cancer in women.Endocr. Rev., 11, 221–265 (1990).

    PubMed  CAS  Article  Google Scholar 

  8. Santen, R. J., Martel, J. and Hoagland, M.: Stromal spindle cells contain aromatase in human breast tumors.J. Clin. Endocrinol. Metab., 79, 627–632 (1994).

    PubMed  Article  CAS  Google Scholar 

  9. Siiteri, P. K.: Review of studies on estrogen biosynthesis in the human.Cancer Res., 42, 3269s-3273s (1982).

    PubMed  CAS  Google Scholar 

  10. Thompson, E. A. and Siiteri, P. K.: The involvement of human placental microsomal cytochrome P-450 in aromatization.J. Biol. Chem., 249, 5373–5378 (1974a).

    PubMed  CAS  Google Scholar 

  11. Thompson, E. A. and Siiteri, P. K.: Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione.J. Biol. Chem., 249, 5364–5372 (1974b).

    PubMed  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to John M. Pezzuto.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Jeong, H.J., Shin, Y.G., Kim, I.H. et al. Inhibition of aromatase activity by flavonoids. Arch Pharm Res 22, 309 (1999).

Download citation

Key words

  • Aromatase inhibition
  • Flavonoids
  • Breast cancer